Technical Analysis for GBS - GBS Inc.

Grade Last Price % Change Price Change
F 5.2 -0.19% -0.01
GBS closed down 4.75 percent on Monday, April 12, 2021, on 13 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical GBS trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish -0.19%
Stochastic Reached Oversold Weakness -0.19%
Wide Bands Range Expansion -0.19%
Down 3 Days in a Row Weakness -0.19%
Down 4 Days in a Row Weakness -0.19%
Down 5 Days in a Row Weakness -0.19%
Oversold Stochastic Weakness -0.19%
Narrow Range Bar Range Contraction -4.94%
Wide Bands Range Expansion -4.94%
Down 3 Days in a Row Weakness -4.94%
Older End-of-Day Signals for GBS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% about 6 hours ago
Up 1% about 6 hours ago
60 Minute Opening Range Breakdown 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It operates in Mainland China, Hong Kong, Vietnam, and Bangladesh. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Diabetes Tumor Glucose Diagnostic Tests Biomarkers Blood Glucose Monitoring Monitoring Diabetes Management Chemical Pathology Biosensor

Is GBS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.2399
52 Week Low 5.03
Average Volume 358,402
200-Day Moving Average 0.00
50-Day Moving Average 6.74
20-Day Moving Average 5.99
10-Day Moving Average 5.55
Average True Range 0.46
ADX 24.22
+DI 12.76
-DI 30.80
Chandelier Exit (Long, 3 ATRs ) 5.86
Chandelier Exit (Short, 3 ATRs ) 6.41
Upper Bollinger Band 7.12
Lower Bollinger Band 4.86
Percent B (%b) 0.15
BandWidth 37.66
MACD Line -0.39
MACD Signal Line -0.38
MACD Histogram -0.0127
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.69
Resistance 3 (R3) 5.72 5.60 5.61
Resistance 2 (R2) 5.60 5.47 5.58 5.58
Resistance 1 (R1) 5.40 5.40 5.34 5.37 5.56
Pivot Point 5.28 5.28 5.25 5.26 5.28
Support 1 (S1) 5.08 5.15 5.02 5.05 4.86
Support 2 (S2) 4.96 5.08 4.94 4.84
Support 3 (S3) 4.76 4.96 4.81
Support 4 (S4) 4.73